Skip to main content
Retour
Watch Compare

EUDA Health Holdings Ltd

Qualité des données : 100%
Également cotée sous EUDAW Nasdaq
EUDA
Nasdaq Services Health Services
7,21 €
▲ 0,21 € (3,00%)
Cap. Boursière: 13,63 M
Prix
7,21 €
Cap. Boursière
13,63 M
Fourchette du Jour
7,21 € — 7,21 €
Fourchette 52 Semaines
6,42 € — 86,00 €
Volume
944
Ouverture 7,21 €
Moyenne 50J / 200J
16,24 €
55,59% below
Moyenne 50J / 200J
42,47 €
83,02% below

Quick Summary

Points Clés

Negative free cash flow of -2,11 M
P/E of 51,11 — premium valuation
Capital efficient — spends only 2,30% of revenue on capex

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)8,22%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin5,17%
Op. Margin-41,13%

Sécurité

Debt / Equity
N/A
Current Ratio0,23
Interest CoverageN/A

Valorisation

PE (TTM)
51,11
Au-dessus de la moyenne du secteur (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (502 pairs)
Métrique Action Médiane du Secteur
P/E 51,1 -1,2
P/B — 1,4
ROE % — -15,7
Net Margin % 5,2 -18,3
Rev Growth 5Y % — 4,2
D/E — 0,4

All Fundamental Metrics
Growth
Revenue Growth (1Y) 8,22% Revenue Growth (3Y) -36,16%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 5,16 M Net Income (TTM) 266 672,0
ROE N/A ROA 12,85%
Gross Margin 22,39% Operating Margin -41,13%
Net Margin 5,17% Free Cash Flow (TTM) -2,11 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,23
Interest Coverage N/A Asset Turnover 2,49
Working Capital -4,40 M Tangible Book Value -3,97 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio 51,11 Forward P/E N/A
P/B Ratio N/A P/S Ratio 2,64
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -15,48%
Market Cap 13,63 M Enterprise Value 13,63 M
Per Share
EPS (Diluted TTM) 0,09 Revenue / Share 2,73
FCF / Share -1,12 OCF / Share -1,05
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 2,30% FCF Conversion -791,38%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022
Revenue 4,01 M 3,71 M 9,84 M
Net Income -15,36 M -10,04 M -24,88 M
EPS (Diluted) -0,47 -0,44 —
Gross Profit 762 155,0 842 075,0 3,35 M
Operating Income -17,34 M -3,96 M -12,06 M
EBITDA — — —
R&D Expenses — — 17 209,0
SG&A Expenses — — —
D&A 173 217,0 — —
Interest Expense — — —
Income Tax -4 379,0 -20 789,0 17 422,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022
Total Assets 1,70 M 1,31 M 25,63 M
Total Liabilities 4,27 M 8,79 M 29,14 M
Shareholders' Equity -2,55 M -7,50 M -3,52 M
Total Debt — — —
Cash & Equivalents — 189 005,0 143 024,0
Current Assets 762 876,0 723 441,0 25,03 M
Current Liabilities 4,14 M 8,72 M 29,12 M